Literature DB >> 19323302

The growing importance of skin toxicity in EGFR inhibitor therapy.

Mario E Lacouture1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19323302

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  6 in total

1.  E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication.

Authors:  Mindy Hartgers; Aminah Jatoi
Journal:  J Palliat Med       Date:  2010-03       Impact factor: 2.947

2.  Chemotherapy and skin reactions.

Authors:  Gabriella Fabbrocini; Norma Cameli; Maria Concetta Romano; Maria Mariano; Luigia Panariello; Dario Bianca; Giuseppe Monfrecola
Journal:  J Exp Clin Cancer Res       Date:  2012-05-28

3.  A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis.

Authors:  Janja Ocvirk; Steffen Heeger; Philip McCloud; Ralf-Dieter Hofheinz
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

4.  The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study.

Authors:  Jaewon Lee; Jin Lim; Jong Seo Park; Miso Kim; Tae-Yong Kim; Tae Min Kim; Kyung-Hun Lee; Bhumsuk Keam; Sae-Won Han; Je-Ho Mun; Kwang Hyun Cho; Seong Jin Jo
Journal:  Cancer Res Treat       Date:  2017-12-14       Impact factor: 4.679

5.  Panitumumab-induced acneiform rash in a patient with metastatic colon adenocarcinoma.

Authors:  Paulo Ricardo Saquete Martins-Filho; Simone Yuriko Kameo; Ana Carolina Mascarenhas-Oliveira; Nivaldo Farias Vieira; André Luis de Santana Peixoto
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

6.  Randomized double-blind trial of prophylactic topical Evozac(®) Calming Skin Spray for gefitinib-associated acne-like eruption.

Authors:  Yalan Wang; Yunpeng Yang; Jinxia Xu; Juan Yu; Xia Liu; Ruizhen Gao; Li Zhang
Journal:  Onco Targets Ther       Date:  2014-07-10       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.